Home

Aarti Pharmalabs Ltd EPS

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

EPS

₹ 27.51

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Aarti Pharmalabs Ltd is ₹ 27.51 as of 21 Feb 25 .
  • The earning per share of Aarti Pharmalabs Ltd changed from ₹ 5.2 to ₹ 8.16 over 7 quarters. This represents a CAGR of 29.37% .

Historical Earning per Share of Aarti Pharmalabs Ltd

No data available

* All values are in

Company Fundamentals for Aarti Pharmalabs Ltd

Market Cap

6,923 Cr

EPS

27.5

P/E Ratio (TTM)

27.8

P/B Ratio (TTM)

3.7

Day’s High

803.15

Day’s Low

754.2

DTE

0.2

ROE

12.3

52 Week High

837.0

52 Week Low

380.65

ROCE

14.9

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025764
20 Feb 2025780.1
19 Feb 2025802.55
18 Feb 2025807.7
17 Feb 2025789.55
14 Feb 2025720
13 Feb 2025733.45
12 Feb 2025741.7
11 Feb 2025718.3
10 Feb 2025738.7

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aarti Pharmalabs Ltd

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

6,924

Asset Value

Value addition

4.4 X

1,278

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Aarti Pharmalabs Ltd6923
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aarti Pharmalabs Ltd News Hub

Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter

Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as again

Read more

05 Aug 24

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024. Po

Read more

22 Oct 24

Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter

Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as a

Read more

28 Oct 24

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position o

Read more

28 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Aarti Pharmalabs Ltd

What is the EPS of Aarti Pharmalabs Ltd stock?

The Earnings Per Share (EPS) of Aarti Pharmalabs Ltd is 27.51. An EPS is the amount of net income attributed to each share of a common stock.

How is Aarti Pharmalabs Ltd EPS calculated?

The EPS of Aarti Pharmalabs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aarti Pharmalabs Ltd report its EPS?

Aarti Pharmalabs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aarti Pharmalabs Ltd EPS?

Factors that influence the EPS of Aarti Pharmalabs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aarti Pharmalabs Ltd EPS growth indicate future performance?

Yes, consistent growth in Aarti Pharmalabs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions